Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Emerging Authors Program for building cardiovascular disease prevention and management research capacity in low- and middle-income countries: a collaboration of the U.S. Centers for Disease Control and Prevention, the Lancet Commission on Hypertension Group, Resolve to Save Lives, and the World Hypertension League

Journal of Human Hypertension volume 38, pages 380–381 (2024)Cite this article

Subjects

The Emerging Authors Program (EAP) for Global Cardiovascular Disease Research is an opportunity for early and mid-career health trainees and practitioners from low- and middle-income countries (LMICs) to apply to receive scientific writing and publication mentorship from global cardiovascular disease experts. The EAP and this publication are a great example of advancing the Global Health Equity Agenda that the Center for Global Health is striving to achieve – particularly around reducing disparities in global health research and knowledge production in LMICs. In early 2021, a call for applications was announced for the EAP to expand the evidence-base cardiovascular disease (CVD) prevention, management, and control with the primary aim to build the scientific publication capacity in LMICs [1]. This program collaborates with the Lancet Commission on Hypertension Group (LCOHG), Resolve to Save Lives (RTSL), the U.S. Centers for Disease Control and Prevention (CDC), and the World Hypertension League (WHL). These organizations’ subject matter experts provide mentorship to selected authors helping them strengthen their scientific writing skills and navigate the writing and publication process.

The EAP continues to make strides despite the challenges imposed by the COVID-19 pandemic. The program has resulted in 18 publications from 10 different countries across three special sections since its launch in early 2020 [1,2,3]. The authors in the first two sections were mentored by global experts from WHL, RTSL, or the LCOHG without actively engaging in-country mentors. In this third and current special section, in-country mentors were invited to collaborate with global mentors to create sustainable capacity. Furthermore, to better understand the strengths and challenges of this approach, the authors and in-country mentors were invited to respond to a brief anonymous survey after their manuscripts were accepted for publication. Eighty percent of those invited responded to the survey providing insightful feedback. This editorial highlights their experiences.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Neupane D, Hall B, Mukhtar, Q, Delles C, Sharman J, Cobb, L, et al. Emerging Authors Program for Global Cardiovascular Disease Research-A collaboration of the U.S. Centers for Disease Control and Prevention, the Lancet Commission on Hypertension Group, Resolve to Save Lives, and the World Hypertension League. J Hum Hypertens. 2022:1–2, https://doi.org/10.1038/s41371-022-00678-w.

  2. Neupane D, Cobb LK, Hall B, Lackland DT, Moran AE, Mukhtar Q, et al. Building research capacity within cardiovascular disease prevention and management in low- and middle-income countries: a collaboration of the US Centers for Disease Control and Prevention, the Lancet Commission on Hypertension Group, Resolve to Save Lives, and the World Hypertension League. J Clin Hypertens. 2021;23:699–701.

    Article  Google Scholar 

  3. Olsen MH, Neupane D, Cobb LK, Frieden TR, Hall B, Lackland DT, et al. Global cardiovascular disease prevention and management: a collaboration of key organizations, groups, and investigators in low- and middle-income countries. J Clin Hypertens. 2020;22:1293–5.

    Article  Google Scholar 

Download references

Acknowledgements

The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the U.S. Centers for Disease Control and Prevention.

Author information

Authors and Affiliations

  1. Lancet Commission on Hypertension Group, London, UK

    Dinesh Neupane, Christian Delles, James E. Sharman & Michael H. Olsen

  2. Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA

    Dinesh Neupane

  3. Centers for Disease Control and Prevention, Atlanta, GA, USA

    Qaiser Mukhtar

  4. CDC Foundation, Atlanta, GA, USA

    Elizabeth Kay Krajan Pardo

  5. Graham Technologies LLC, Upper Marlboro, MD, USA

    Sushama D. Acharya

  6. Institute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, UK

    Christian Delles

  7. Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia

    James E. Sharman

  8. Resolve to Save Lives, New York, NY, USA

    Laura Cobb & Andrew Moran

  9. World Hypertension League, Charleston, SC, USA

    Daniel T. Lackland & Michael A. Weber

  10. Medical University of South Carolina, Charleston, SC, USA

    Daniel T. Lackland

  11. State University of New York, New York, NY, USA

    Michael A. Weber

  12. Department of Internal Medicine, Holbaek Hospital, Holbaek, Denmark

    Michael H. Olsen

  13. Department of Regional Health Research, University of Southern Denmark, Odense, Denmark

    Michael H. Olsen

Authors
  1. Dinesh Neupane
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qaiser Mukhtar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elizabeth Kay Krajan Pardo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sushama D. Acharya
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Christian Delles
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. James E. Sharman
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Laura Cobb
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Daniel T. Lackland
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Andrew Moran
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Michael A. Weber
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Michael H. Olsen
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

DN wrote the initial draft of the Editorial. QM, DN, EK, SDA, CD, JES, LKC, DTL, AEM, MAW, and MHO are collaborating partners who contributed to the conception and design of this mentorship program; they also provided critical feedback to the final draft of the Editorial. All authors contributed to this Editorial’s development and approved the final version.

Corresponding author

Correspondence to Dinesh Neupane.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Neupane, D., Mukhtar, Q., Krajan Pardo, E.K. et al. Emerging Authors Program for building cardiovascular disease prevention and management research capacity in low- and middle-income countries: a collaboration of the U.S. Centers for Disease Control and Prevention, the Lancet Commission on Hypertension Group, Resolve to Save Lives, and the World Hypertension League. J Hum Hypertens 38, 380–381 (2024). https://doi.org/10.1038/s41371-023-00880-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41371-023-00880-4

Search

Advanced search

Quick links